FindTrial
Sign In

Influence of partial splenic embolization on the portal and splenic hemodynamics of patients with hypersplenism and its noninvasive evaluations

Influence of partial splenic embolization on the portal and splenic hemodynamics of patients with hypersplenism and its noninvasive evaluations

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16009693
Enrollment
Unknown
Registered
2016-10-30
Start date
2017-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

portal hypersplenism

Interventions

Case series:partial splenic embolization

Sponsors

Renji Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. patients with hypersplenism caused by liver cirrhosis; 2. patients with hypersplenism caused by portal vein tumor thrombus (incomplete obstruction).

Exclusion criteria

Exclusion criteria: 1. Patients with portal vein or splenic vein thrombi diagnosed by CT examination; 2. Patients who received treatment of drugs known to influence hemodynamics of portal vein or splenic vein, such as b-blockers; 3. Patients with other interventional treatment, such as peritoneovenous shunt; 4. Patients with obvious arteriovenous shunt were excluded.

Design outcomes

Primary

MeasureTime frame
portal vein pressure; splenic vein pressure;—

Countries

China

Contacts

Public ContactJialin Shen

Renji Hospital, Shanghai Jiao Tong University School of Medicine

Shenjialin123@163.com+86 13501794493

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026